Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
- PMID: 17664231
- DOI: 10.1177/0961203307079042
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Abstract
The objective of this study was to determine the factors predictive of time to the occurrence of pulmonary damage in systemic lupus erythematosus (SLE). Six-hundred and twenty-six SLE patients from a multiethnic (Hispanics, African Americans and Caucasians) longitudinal study of outcome were studied. Pulmonary damage was defined as per the Systemic Lupus International Collaborating Clinics Damage Index. Socioeconomic-demographic, clinical, genetic, serological features, pharmacologic treatments, behavioural, psychological and disease activity [as per the Systemic Lupus Activity Measure-Revised (SLAM-R)] were examined. Factors associated with time to the occurrence of pulmonary damage were examined by Cox proportional hazards regressions. A Kaplan-Meier survival curve was also examined. Forty-six (7.3%) patients had pulmonary damage after a mean (SD) total disease duration of 5.3 (3.6) years. Among those patients, 25 had pulmonary fibrosis, 12 pulmonary hypertension, eight pleural fibrosis, four pulmonary infarction and four shrinking lung syndrome. Seven patients had more than one type of lung damage. Cumulative rates of pulmonary damage at five and 10 years were 7.6% and 11.6%, respectively. In the multivariable analyses, age (HR = 1.033, 95% CI 1.006-1.060; P = 0.0170), pneumonitis (HR = 2.307, 95% CI 1.123-4.739; P = 0.0229) and anti-RNP antibodies (HR = 2.344, 95% CI 1.190-4.618; P = 0.0138) were associated with a shorter time to the occurrence of pulmonary damage while photosensitivity (HR = 0.388, 95% CI 0.184-0.818; P = 0.0128) and oral ulcers (HR = 0.466, 95% CI 0.230-0.942; P = 0.0335) with a longer time. Pulmonary damage is relatively common in SLE. Age, pneumonitis and anti-RNP antibodies were associated with a shorter time to the development of permanent lung disease.
Similar articles
-
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage.Arthritis Rheum. 2004 Oct;50(10):3177-86. doi: 10.1002/art.20578. Arthritis Rheum. 2004. PMID: 15476246
-
Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.Arthritis Care Res (Hoboken). 2010 Mar;62(3):393-400. doi: 10.1002/acr.20097. Arthritis Care Res (Hoboken). 2010. PMID: 20391486 Free PMC article.
-
Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity.Lupus. 2006;15(1):13-8. doi: 10.1191/0961203306lu2256oa. Lupus. 2006. PMID: 16482740
-
What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?Autoimmun Rev. 2004 Jun;3(4):321-9. doi: 10.1016/j.autrev.2003.11.005. Autoimmun Rev. 2004. PMID: 15246029 Review.
-
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort: The LUMINA (Lupus in Minorities: Nature vs. Nurture) Experience (LUMINA LXXXII).Rheum Dis Clin North Am. 2021 Feb;47(1):55-64. doi: 10.1016/j.rdc.2020.09.002. Epub 2020 Oct 29. Rheum Dis Clin North Am. 2021. PMID: 34042054 Review.
Cited by
-
Choosing pharmacotherapy for ILD in patients with connective tissue disease.Breathe (Sheff). 2021 Dec;17(4):210114. doi: 10.1183/20734735.0114-2021. Breathe (Sheff). 2021. PMID: 35035571 Free PMC article.
-
New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden.Arthritis Res Ther. 2019 Feb 6;21(1):48. doi: 10.1186/s13075-018-1804-8. Arthritis Res Ther. 2019. PMID: 30728079 Free PMC article.
-
Severe cognitive dysfunction and shrinking lung syndrome in systemic lupus erythematous.Autops Case Rep. 2014 Mar 30;4(4):63-69. doi: 10.4322/acr.2014.041. eCollection 2014 Oct-Dec. Autops Case Rep. 2014. PMID: 28573131 Free PMC article.
-
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.Ann Rheum Dis. 2022 Nov;81(11):1541-1548. doi: 10.1136/ard-2022-222487. Epub 2022 Aug 9. Ann Rheum Dis. 2022. PMID: 35944946 Free PMC article.
-
Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review.J Clin Med. 2022 Nov 13;11(22):6714. doi: 10.3390/jcm11226714. J Clin Med. 2022. PMID: 36431192 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical